Business Context and Reporting Period
Milestone Scientific Inc. filed a Form 8-K on October 8, 2025, reporting a notice from NYSE American LLC regarding non-compliance with continued listing standards. The company is incorporated in Delaware and maintains its principal executive offices in Livingston, New Jersey.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The notice of delisting cites non-compliance with Section 1003(a)(ii) and (iii) of the NYSE American Company Guide, which typically relate to minimum bid price and shareholder equity requirements, but the specific financial figures triggering this notice are not disclosed in this document.
Material Changes
The primary material change is the receipt of a formal notice from the Exchange stating the company is not in compliance with listing standards. This status change requires the company to submit a compliance plan by November 7, 2025, to avoid potential delisting procedures.
Guidance, Outlook, and Risks
Management intends to submit a compliance plan by the November 7, 2025 deadline. If the plan is accepted, the company may continue listing subject to periodic reviews. However, if the plan is rejected, or if the company fails to regain compliance by April 8, 2027, or fails to make consistent progress, the Exchange will initiate delisting procedures. The primary risk is the potential loss of the company's listing on NYSE American.
Investor Verification Checklist
- Verify the specific financial metrics (e.g., bid price, equity) that caused the non-compliance with Sections 1003(a)(ii) and (iii).
- Confirm the submission and acceptance status of the compliance plan by November 7, 2025.
- Monitor subsequent filings for updates on the company's progress toward regaining compliance before the April 8, 2027 deadline.
- Review the company's most recent 10-K or 10-Q for detailed financial statements not included in this 8-K.